Priority Date: 23.07.10 (US 20100367048P)

NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS

  • Application ID: EP11810217
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
4 offices
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Merck & Co. Inc. is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 230 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 23.07.2010 - Priority Date (US 20100367048P)
  • 26.01.2012 - Publication A1 (WO2012012314)
  • 29.05.2013 - Publication A1 (EP2595483)
  • 22.03.2017 - Publication B1 (EP2595483)